ARTICLE | Company News
Roche asks CHMP to re-examine Tarceva
September 6, 2006 1:58 AM UTC
Roche (SWX:ROCZ) said it asked EMEA's CHMP to re-examine the data supporting a label expansion for Tarceva erlotinib plus gemcitabine to treat advanced pancreatic cancer. The agency issued a negative ...